Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery? - Wikidata - wikimedia - TriplyDB

Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

http://www.wikidata.org/entity/Q47736742

about

Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

http://www.wikidata.org/entity/Q47736742

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

@en

Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

@nl

type

label

Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

@en

Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

@nl

prefLabel

Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

@en

Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

@nl

P1433

Q47736742-C8BEC815-42D1-41E1-AEB7-0539AB77F332

P1476

Q47736742-A5B3687F-2D5A-426A-BE59-699CAE6C04F9

P2093

Q47736742-194C86CC-D44B-471F-94D4-BAEB8E7D156D

Q47736742-E2242977-D86B-4624-A65F-5595536780BC

P275

Q47736742-5A271351-1BAE-4047-AF2B-8E03B3D2A20D

P2860

Q47736742-02E3E6C4-C570-4BAC-A7A8-7932BFC3DD5D

Q47736742-054C7CD7-928B-4B38-B46A-2DB222EDAAB2

Q47736742-0E7D3D68-4F1B-486A-91C5-0548961C5AC6

Q47736742-0ECC81E8-EC6A-489D-871D-E7EDB70C705C

Q47736742-0F5C930F-B157-4C1F-8C62-A3ED2319CF1D

Q47736742-126E88A3-B501-421E-AC17-0FBF5E269750

Q47736742-3CC3C425-0CE7-45F4-ADDC-5BD4A7D39B54

Q47736742-45F7F370-E54C-4119-8BDB-DAAC8421BA70

Q47736742-46BFA973-546E-4A7A-B082-10AAC8A15904

Q47736742-562142E2-CBE3-4FCF-8A2C-EB150B976453

P2888

Q47736742-3BAEE08E-1CBB-489A-AB75-51AB64A3E52C

P304

Q47736742-70DBD679-A4CE-49C9-85CB-96414103D492

P31

Q47736742-55E9C2BD-5F97-4C3F-9888-89DBB76B02E9

Q47736742-F8F2276B-23CE-4192-8F15-EDAD9AAD9C22

P356

Q47736742-BC10D595-6F18-4108-A412-9738A18CD042

P433

Q47736742-3AB5B565-D374-4A5F-8A65-E8E9F97C1CE2

P478

Q47736742-CB151201-35A2-4E3E-9E50-35A1B67CC3CD

P50

Q47736742-04C8B85E-58E8-42A9-B771-23F00C60AF4D

Q47736742-2A507897-7469-4201-BE42-784BF71C44D1

P577

Q47736742-67D60298-9AC0-400F-8FBF-2427A576B3DB

Q47736742-916CFAA3-BBC9-4DE9-9E9D-76B9B313D709

P698

Q47736742-29B9A2E2-77B1-4E07-9885-3F08812B3B59

P921

Q47736742-0D09FB5F-862B-4CD1-A6C3-6B90273368EA

Q47736742-7197F9F4-90A8-4931-8303-1A79F45D1520

Q47736742-7C408D29-8F67-4C0D-94D2-2BB4B798DC71

Q47736742-D62D4F32-24D9-4284-B91F-8096C332579C

Q47736742-F3605D74-4780-41BE-A2F5-0ABDB203B23E

Q47736742-FBF144F6-C342-4D9A-B844-145480DCAA83

P932

Q47736742-58E20E24-4761-4B19-8E4B-14281A880B64

P356

S12035-017-0501-Y

P1433

Molecular Neurobiology

P1476

Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery?

@en

P2093

João Casaca-Carreira

http://www.w3.org/2001/XMLSchema#string

Sarah-Anna Hescham

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

Current approaches to enhance CNS delivery of drugs across the brain barriers

Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system.

Low-dose acetazolamide reverses periventricular white matter hyperintensities in iNPH.

Cerebrospinal fluid dynamics.

Proposal of "evolution theory in cerebrospinal fluid dynamics" and minor pathway hydrocephalus in developing immature brain.

Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics.

Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.

P2888

s12035-017-0501-y

P304

2780-2788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-017-0501-Y

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28455692

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

biomedical investigative technique

fluids and secretions

P932

5842497

http://www.w3.org/2001/XMLSchema#string